Fluid balance in patients with chronic renal failure assessed with N-terminal proatrial natriuretic peptide, Atrial Natriuretic Peptide and ultrasonography

Acta Physiologica Scandinavica

Volumn 171, Issue 2, 2001, Pages 117-122

  Metry, G ^a,c   Hall, C ^b   Wikstrom B ^a   Kallskog V ^a   Hansell, P ^a   Danielson, B ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF OSLO   (Norway)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

ANP; cGMP; Haemodialysis; Hydration; Inferior vena cava; N terminal proANP; Ultrasonography

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CREATININE; CYCLIC GMP; N TERMINAL PROATRIAL NATRIURETIC PEPTIDE; N-TERMINAL PROATRIAL NATRIURETIC PEPTIDE; PROTEIN PRECURSOR;

ADULT; AGED; ARTICLE; BLOOD; CHRONIC KIDNEY FAILURE; ECHOGRAPHY; ELECTROLYTE BALANCE; FEMALE; HUMAN; INFERIOR CAVA VEIN; MALE; MIDDLE AGED; PROGNOSIS; REFERENCE VALUE; RENAL REPLACEMENT THERAPY;

ADULT; AGED; ATRIAL NATRIURETIC FACTOR; CREATININE; CYCLIC GMP; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROGNOSIS; PROTEIN PRECURSORS; REFERENCE VALUES; RENAL DIALYSIS; VENA CAVA, INFERIOR; WATER-ELECTROLYTE BALANCE;

EID: 0035260141     PISSN: 00016772     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-201x.2001.00792.x     Document Type: Article

References (27)

1. Biollaz, J., Callahan, L., Nussberger, J. et al. 1987. Pharmacokinetics of synthetic atrial natriuretic peptides in normal men. Clin Pharmacol Ther 41, 671-677.
2. Boomsma, F., Bhaggoe, U., Veld, A. & Schalekmp, A. 1996. Comparison of N-terminal proatrial natriuretic peptide in human plasma as measured with commercially available radioimmunoassay kits. Clin Chem Acta 252, 41-49.
3. Cheriex, E., Leunissen, K., Janssen, J., Mooy, j. & Van Hoof, J. 1989. Echography of the vena cava inferior is a simple reliable tool for estimation of 'dry weight' in haemodialysis patients. Nephrol Dial Transplant 4, 363-368.
4. Christensen, G., Aksnes, G., Ilbekk, A. & Kiil, F. 1991. Release of atrial natriuretic factor during selective cardiac alpha- and beta-adrenergic stimulation, intraaortic calcium infusion and aortic constriction in pigs. Circ Res 68, 638-644.
5. DeBold, A.H., Borenstein, H., Veress, A. & Sonnenberg, H. 1981. Rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rat. Life Sci 28, 89-94.
6. Dietz, J., Vesely, D. & Nazian. S. 1992. Effect of changes in sodium intake on atrial natriuretic factor (ANF) and peptides derived from the N-terminus of the ANF prohormone in the rat. Proc Soc Exp Biol Med 200, 44-48.
7. Hall, C., Aaberg, L. & Stokke, O. 1995. In vitro stability of N-terminal proatrial natriuretic factor in unfrozen samples: an important prerequisite for its use as a biochemical parameter of atrial pressure in clinical routine. Circulation (Letter) 91, 911.
8. Hall, C., Rouleau, J., Moyè, L. et al. 1994. N-terminal proatrial ntriuretic factor. An independent predictor of long-term prognosis after myocardial infarction. Circulation 89, 1934-1942.
9. Heim, J., Gottmann, K., Weil, J., Haufe, M. & Gerzer, R. 1988. Is cyclic GMP a clinically useful marker for ANF action? Z Kardiol 77(Suppl. 2), 41-46.
10. Itoh, H., Nakao, K., Sugawara, A. et al. 1988. Gamma-atrial natriuretic polypeptide (gamma ANP)-derived peptides in human plasma: cosecretion of N-terminal gamma ANP fragment and alpha ANP. J Clin Endocrinol Metab 67, 429-437.
11. Kouw, P., Kooman, J., Cheriex, E., Olthof, C., DeVries, P. & Leunissen, K. 1993. Assessment of postdialysis dry weight: a comparison of techniques. J Am Soc Nephrol 4, 98-104.
12. Lerman, A., Gibbons, R., Rodeheffer, R. et al. 1993. Circulating N-terminal atrial natriutretic peptide as a marker for symptomless left-ventricular dysfunction. Lancet 341, 1105-1109.
13. Leunissen, K., Kouw, P., Kooman, J. et al. 1993. New techniques to determine fluid status in hemodialyzed patients. Kidney Int 43 (Suppl. 41), S50-S56.
14. Maack, T., Nikonova, L., Friedman, O. & Cohen, D. 1996. Functional properties and dynamics of natriuretic peptide receptors. Proc Soc Exp Biol Med 213, 109-116.
15. Mathisen, P., Hall, C. & Simonsen, S. 1993. Comparative study of atrial peptides ANF (1-98) and ANF (99-126) as diagnostic markers of atrial distension in patients with cardiac diseases. Scand J Lab Clin Invest 53, 41-49.
16. Metry, G., Wegenius, G., Wikström, B. et al. 1997. Lung density for assessment of hydration status in haemodialysis patients using the computed tomographic densitometry technique. Kidney Int 52, 1635-1644.
17. Nakaoka, H., Imitaka, K., Amano, M., Fujii, J., Ishibashi, M. & Yamaji, T. 1985. Plasma levels of atrial natriuretic factor in patients with congestive heart failure. N Engl J Med 313, 892-893.
18. Natori, H., Tamaki, S. & Kira, S. 1979. Ultrasonographic evaluation of ventilatory effect on inferior vena caval configuration. Am Rev Resp Dis 4, 421-427.
19. Neugent, A., Onouha, G., McEneaney, D. et al. 1994. Variable pattern of atrial natriuretic peptide secretion in man. Eur J Clin Invest 24, 267-274.
20. Raine, A., Bock, A., Müller, F. et al. 1989. Comparative effects of haemodialysis and hemofiltration on plasma atrial natriuretic peptide. Nephrol Dial Transplant 4, 222-227.
21. Ruskoaho, H. 1992. Atrial natriuretic peptide: synthesis, release, and metabolism. Pharmacol Rev 44, 479-602.
22. Saxenhover, H., Gnädinger, M., Weidmann, P. et al. 1987. Plasma levels and dialysance of atrial natriuretic peptide in terminal renal failure. Kidney Int 32, 554-561.
23. Shiota, J., Kubota, M., Hamada, C. & Koide, H. 1990. Plasma atrial natriuretic peptide during haemodialysis with or without fluid removal. Nephron 55, 283-286.
24. Sundsfjord, J., Thibault, G., Larochelle, P. & Cantin, M. 1988. Identification and plasma concentrations of the N-terminal fragment of proatrial natriuretic factor in man. J Clin Endocrinol Metab 66, 605-610.
25. 2-terminal fragment of rat proatrial natriuretic factor in the circulation: identification, radioimmunoassay and half-life. Peptides 9, 47-53.
26. Vesely, D., Preston, R., Winters, C., Rico, D., Sallman, A. & Epstein. M. 1991. Increased release of the N-terminal and C-terminal portions of the atrial natriuretic factor prohormone during immersion-induced hypervolaemia in cirrhotic humans. Am J Nephrol 11, 207-216.
27. Yandle, T., Espiner, E., Nicholls, M. & Duff, M. 1986. Radioimmunoassay and characterisation of atrial natriuretic peptide in human plasma. J Clin Endcrinol Metab 63, 72-79.